Wide abstract illustration of a value bridge supported by pillars for quality, transparency, accountability, and dignity, with red shortcut fragments falling away.
H&M invented a new kind of shrinkflation, taking the size of male underwear down. L suddenly […]
Abstract wide illustration showing Japan drug pricing from listing to post-launch revisions, using blue shapes on a sand background with red trigger markers.
On December 12, 2025, Japan’s Ministry of Health, Labour and Welfare (MHLW) tabled a draft outline […]
Photorealistic scene of a consultant in a Tokyo meeting room connecting a foreign company with Japanese pharma executives.
You fly in, you present, you charm the room. Heads nod. The technical team likes your […]
Abstract flat illustration of Japanese blockbuster drugs falling off a 2026 PMP price cliff with coloured bars and icons for key therapy areas.
Japan’s pharmaceutical market is about to run a high-stakes experiment in how hard a mature health […]
Abstract illustration of Toronto’s biomedical innovation cluster centered on MaRS, research institutes, and startups.
Something quietly extraordinary has been happening in the heart of downtown Toronto. Within one of the […]
Selfie on the BioJapan 2025 exhibition floor: attendee in foreground, crowded aisles with posters and company booths, “AIST” jacket visible, signage directing to partnering zones.
The surge I sensed at BioJapan 2025 in October reflects deliberate engineering rather than hype: targeted […]
Abstract landscape of sand-toned islands linked by light-blue channels, with dark-blue bio-factory shapes and red markers suggesting biologics flow across Japanese hubs.
A New Order is taking shape in Japan’s life sciences. Conference floors are packed, university benches […]
Two executives in a golden-yellow meeting room lean over a large sheet of paper spread across the table. They are animatedly pointing and gesturing, immersed in discussion, as if the printed spreadsheet in front of them holds the key to their success in Japan’s pharma market.
An A3 Executive Reference (2 pages) Japan rewards programs that are sequenced, evidenced, and locally socialized. […]
Two smiling businesswomen in an office with a view of Tokyo, collaborating on a whiteboard with flowcharts and a large corkboard filled with colorful sticky notes.
Cracking Japan’s Pharma Ecosystem: Field Notes from ~20 Years in the Trenches Japan rewards sequencing, proof, […]
Abstract representation of Moderna's diversified mRNA pipeline targeting Japan’s infectious and rare diseases.
As mRNA biotechnology matures, few firms have demonstrated a shift as dynamic as Moderna. Widely recognised […]